Literature DB >> 22920745

Breathlessness, night sweats, and weight loss on natalizumab.

D Dahdaleh, D M Altmann, O Malik, R S Nicholas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920745     DOI: 10.1016/S0140-6736(12)61401-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

Review 2.  Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis.

Authors:  Babak Soleimani; Katy Murray; David Hunt
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

3.  Prevalence of Latent Tuberculosis in the Multiple Sclerosis Clinic and Effect of Multiple Sclerosis Treatment on Tuberculosis Testing.

Authors:  Andrew J Bouley; Ursela Baber; Emily Egnor; Soleil Samaan; Jacob A Sloane
Journal:  Int J MS Care       Date:  2020-04-14

4.  Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

Authors:  Jonas Graf; Verena I Leussink; Thomas Dehmel; Marius Ringelstein; Norbert Goebels; Ortwin Adams; Colin R MacKenzie; Clemens Warnke; Torsten Feldt; Anna Lammerskitten; Luisa Klotz; Sven Meuth; Heinz Wiendl; Hans-Peter Hartung; Orhan Aktas; Philipp Albrecht
Journal:  Ann Clin Transl Neurol       Date:  2017-11-24       Impact factor: 4.511

5.  A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients.

Authors:  Agnese Gugliandolo; Federica Longo; Maria Giovanna Marrosu; Giovanni Luigi Mancardi; Ilaria Gandoglia; Maurizio Melis; Fabrizio Lo Giudice; Placido Bramanti; Emanuela Mazzon
Journal:  Ther Clin Risk Manag       Date:  2018-09-26       Impact factor: 2.423

6.  Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review.

Authors:  Yuichiro Yasuda; Tatsuya Nagano; Motoko Tachihara; Norio Chihara; Kanoko Umezawa; Naoko Katsurada; Masatsugu Yamamoto; Kenji Sekiguchi; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Ther Clin Risk Manag       Date:  2019-11-01       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.